Dose Escalation Could Help Guide Equine Chemotherapy Treatment
No account yet? Register
Studies in humans and other animals have shown that the higher the chemotherapy dose, the more significant its tumor-treating effects. But often, high medication doses cause adverse effects, some of which could be life-threatening. And, in horses, it’s still not clear exactly what the optimal equine chemotherapy treatment dose is for most medications. This means horses with cancer might be receiving less medication than they need to effectively fight the tumors in their bodies.The good news is that researchers are getting closer to figuring out the unknowns by using a process called dose escalation.
“Dose escalation is a strategy of gradual dose increases with careful monitoring for toxicity used to determine the highest tolerated dose and, thereby, higher dose intensity (the active drug dose over time) and maximum efficacy,” said Daniela Luethy, DVM, a large animal internal medicine lecturer at the University of Pennsylvania School of Veterinary Medicine, in Kennett Square.
Luethy and colleagues recently studied the effects of cyclophosphamide (an alkylating agent that interferes with the cancer cell’s DNA and inhibits cancer cell growth) dose escalation in nine horses with lymphoma, a type of hematologic (blood) cancer. She presented the team’s findings at the 2018 American College of Veterinary Medicine Forum, held June 14-16 in Seattle, Washington
Create a free account with TheHorse.com to view this content.
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.
Start your free account today!
Already have an account?
and continue reading.
Related Articles
Stay on top of the most recent Horse Health news with